J. Altenberger

Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus.

A. Parkhomenko, K. Dickstein, M. Nieminen, 2014, International journal of cardiology.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

P. Ponikowski, S. Solomon, M. Pfeffer, 2013, European journal of heart failure.

Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure.

A. Hallas, J. Auer, G. Jakl, 2014, International journal of cardiology.